Caption Management, LLC Xencor Inc Call Options Transaction History

Caption Management, LLC

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q1 2019 May 14, 2019	SELL	$27.85 - $38.09 $2.23 Million - $3.05 Million	-80,000 Closed	0 $0
Q4 2018 Jan 30, 2019	BUY	$32.39 - $42.05 $2.59 Million - $3.36 Million	80,000 New	80,000 $2.89 Million

215

71.5M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.15B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.